Presentation TCT 2015 Review and Perspectives of the Global Registry Data for Antiproliferative Therapies Presenter: John R. Laird Jr October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 Which Patients for TAVR? Will Surgical Risk Stratification Remain the Dominant Strategy in the Future? Presenter: John G. Webb October 11, 2015 More slides + Presentation TCT 2015 TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study Presenter: Piotr Musialek October 13, 2015 Presentation TCT 2015 TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial Presenter: Nirat Beohar October 13, 2015 We Recommend
Presentation TCT 2015 Which Patients for TAVR? Will Surgical Risk Stratification Remain the Dominant Strategy in the Future? Presenter: John G. Webb October 11, 2015
Presentation TCT 2015 TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study Presenter: Piotr Musialek October 13, 2015
Presentation TCT 2015 TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial Presenter: Nirat Beohar October 13, 2015